Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02565641 | A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 63 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00499486 | Sirolimus in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 47 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT01661114 | A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers | completed | Phase 2 | 39 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00260364 | Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer(TARGET) | completed | Phase 1 / Phase 2 | 44 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 60 | Pancreatic Cancer Research TeamOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT01304160 | Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 10 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 5, 2016 | clinicaltrials |
| NCT00882310 | A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer | completed | Phase 2 | 37 | Columbia UniversityOTHER | 0 | Jul 25, 2016 | clinicaltrials |
| NCT00996333 | Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) | completed | Phase 2 | 46 | Columbia UniversityOTHER | 1 | Jul 25, 2016 | clinicaltrials |
| NCT02270554 | A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy | completed | Phase 2 | 120 | Wakayama Medical UniversityOTHER | 1 | Jul 21, 2016 | clinicaltrials |
| NCT00003546 | Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | completed | Phase 2 | 43 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT00026130 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | completed | Phase 2 | 81 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00004190 | Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 59 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00012220 | Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas | completed | Phase 2 | 259 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00026403 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00006467 | Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02382263 | Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer(FRAGANCE) | completed | Phase 1 / Phase 2 | 224 | PH Research, S.L.OTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00696696 | Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT00869258 | Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar | completed | Phase 2 | 32 | Columbia UniversityOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00674973 | A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 207 | Hoffmann-La RocheINDUSTRY | 19 | Jun 17, 2016 | clinicaltrials |
| NCT00871169 | Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 61 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT00416767 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery | completed | Phase 2 | 20 | Federation Francophone de Cancerologie DigestiveOTHER | 0 | May 30, 2016 | clinicaltrials |
| NCT01416662 | Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | completed | Phase 2 | 120 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT02468076 | Radiofrequency Ablation for Biliopancreatic Malignancy(IGNITE-1) | completed | Phase 2 | 18 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01658436 | BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. | completed | Phase 2 | 31 | Novartis PharmaceuticalsINDUSTRY | 9 | May 2, 2016 | clinicaltrials |
| NCT01395017 | Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer(LAPC) | completed | Phase 2 | 202 | Otsuka Pharmaceutical Development & Commercialization, Inc.INDUSTRY | 15 | Apr 8, 2016 | clinicaltrials |
| NCT00383149 | A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer | completed | Phase 2 | 58 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01658943 | Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy(S1115) | completed | Phase 2 | 137 | National Cancer Institute (NCI)NIH | 1 | Mar 9, 2016 | clinicaltrials |
| NCT00587964 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT00100815 | Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer | completed | Phase 2 | 50 | Roswell Park Cancer InstituteOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00456599 | Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer | completed | Phase 2 | 71 | University of Michigan Rogel Cancer CenterOTHER | 2 | Dec 3, 2015 | clinicaltrials |
| NCT00005832 | S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 58 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00461708 | A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival | completed | Phase 2 | 153 | Hoffmann-La RocheINDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00561990 | Nimotuzumab in Adults With Pancreatic Cancer | completed | Phase 2 / Phase 3 | 188 | Oncoscience AGINDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT01454180 | Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets | completed | Phase 2 | 31 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | completed | Phase 2 | 42 | Tony Bekaii-SaabOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT00902291 | A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer | completed | Phase 2 | 205 | Astellas Pharma IncINDUSTRY | 5 | Sep 14, 2015 | clinicaltrials |
| NCT00593866 | Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 / Phase 2 | 50 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 11, 2015 | clinicaltrials |
| NCT00570713 | An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer | completed | Phase 2 | 155 | MorphotekINDUSTRY | 5 | Sep 9, 2015 | clinicaltrials |
| NCT00053924 | Perifosine in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | — | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00733850 | Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer | completed | Phase 2 | 85 | KangLaiTe USAINDUSTRY | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01298011 | Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer | completed | Phase 2 | 25 | Pancreatic Cancer Research TeamOTHER | 1 | Jun 17, 2015 | clinicaltrials |
| NCT02074046 | Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT00660699 | A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | completed | Phase 2 | 50 | Washington University School of MedicineOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT00743379 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 71 | Threshold PharmaceuticalsINDUSTRY | 1 | May 7, 2015 | clinicaltrials |
| NCT00474812 | Dasatinib in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00238199 | Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | completed | Phase 2 | 25 | OHSU Knight Cancer InstituteOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT01587534 | Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) | completed | Phase 2 | 67 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00998322 | A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma | completed | Phase 2 | 34 | Oncolytics BiotechINDUSTRY | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00300950 | Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer | completed | Phase 2 | 176 | GlobeImmuneINDUSTRY | 2 | Apr 6, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Nov 2, 2016source: clinicaltrials